1. Home
  2. CHR vs REVB Comparison

CHR vs REVB Comparison

Compare CHR & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheer Holding Inc.

CHR

Cheer Holding Inc.

HOLD

Current Price

$1.75

Market Cap

3.8M

Sector

Technology

ML Signal

HOLD

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

N/A

Current Price

$1.02

Market Cap

3.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHR
REVB
Founded
2016
2020
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.9M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
CHR
REVB
Price
$1.75
$1.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.0K
37.7K
Earning Date
03-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.68
EPS
0.06
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.47
52 Week High
$2.95
$2.90

Technical Indicators

Market Signals
Indicator
CHR
REVB
Relative Strength Index (RSI) 42.15 44.12
Support Level $1.75 $0.94
Resistance Level $2.01 $1.21
Average True Range (ATR) 0.10 0.08
MACD -0.01 -0.01
Stochastic Oscillator 16.67 31.86

Price Performance

Historical Comparison
CHR
REVB

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Share on Social Networks: